Cortexyme Inc GAIN Trial Interim Analysis Update Call Transcript
Good morning, ladies and gentlemen, and welcome to the Cortexyme GAIN Trial Update conference call. My name is [Dilem] and I'll be your operator for today. As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to your host for today, Hal Mackins. Please proceed.
Thanks, [Dilem], and thanks everyone for joining us today on this conference call to discuss the results of the interim analysis for the GAIN trial. Joining me on the call today are Casey Lynch, our Co-Founder, CEO and Chair, and Mike Detke, our Chief Medical Officer, who will together review and provide context for the details of the interim analysis that were announced via press release earlier this morning. Chris Lowe, the Company's Chief Financial Officer is also here and will join for the question-and-answer session that will follow our prepared remarks.
During the course of our remarks today, we will be making forward-looking statements, including statements relating to the outcome and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |